12th April 2017
- 0 comments
12 April
Crowdcube, has announced another return for investors, after innovative biotech firm Celixir offered its backers an opportunity to realise a proportion of their initial investment. 18% of shareholders choose to sell shares, with the remainder holding on to their full stake. Total returns provided to backers by Crowdcube-funded businesses exceeds £5m.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.